Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25073655 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tetsutaro Abe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita 879-5593, Japan. Hauptthemen laut MEDLINE: Osteogenesis, Spinal Fusion, Parathyroid Hormone-Related Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.
Abstract (Originalsprache)
Both bone morphogenetic protein 2 (BMP-2) and abaloparatide are used to promote bone formation. However, there is no consensus about their optimal administration. We investigated the optimal administration theory for the pairing of BMP-2 and abaloparatide in a rat spinal fusion model. Group I was only implanted in carriers and saline. Carriers with 3 µg of recombinant human BMP-2 (rhBMP-2) were implanted in other groups. Abaloparatide injections were administered three times a week for group III (for a total amount of 120 µg/kg in a week) and six times a week for group IV (for a total amount of 120 µg/kg in a week) after surgery. They were euthanized 8 weeks after the surgery, and we explanted their spines at that time. We assessed them using manual palpation tests, radiography, high-resolution micro-computed tomography (micro-CT), and histological analysis. We also analyzed serum bone metabolism markers. The fusion rate in Groups III and IV was higher than in Group I, referring to the manual palpation tests. Groups III and IV recorded greater radiographic scores than those in Groups I and II, too. Micro-CT analysis showed that Tbs. Sp in Groups III and IV was significantly lower than in Group I. Tb. N in Group IV was significantly higher than in Group I. Serum marker analysis showed that bone formation markers were higher in Groups III and IV than in Group I. On the other hand, bone resorption markers were lower in Group IV than in Group I. A histological analysis showed enhanced trabecular bone osteogenesis in Group IV. Frequent administration of abaloparatide may be suitable for the thickening of trabecular bone structure and the enhancement of osteogenesis in a rat spinal fusion model using BMP-2 in insufficient doses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita 879-5593, Japan.
- School of Physical Therapy, Faculty of Rehabilitation, Reiwa Health Sciences University, Fukuoka 811-0213, Japan.
ORCID-Profile: Tetsutaro Abe, Masashi Miyazaki, Yuta Tsubouchi
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
Zitieren
APA
Abe, T., Miyazaki, M., Sako, N., Kanezaki, S., Tsubouchi, Y., & Kaku, N. (2024). Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073655
Vancouver
Abe T, Miyazaki M, Sako N, Kanezaki S, Tsubouchi Y, Kaku N. Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073655
BibTeX
@article{Abe2024,
author = {Abe, Tetsutaro and Miyazaki, Masashi and Sako, Noriaki and Kanezaki, Shozo and Tsubouchi, Yuta and Kaku, Nobuhiro},
title = {Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25073655}
}
EUVIMED